Trial intelligence / Profile preview

Vinorelbine + Carboplatin vs Gemcitabine + Carboplatin in Metastatic Breast Cancer

NCT04143906Phase 2Unknown

Sponsor
Shandong Cancer Hospital
Start
Oct 2019
Primary completion
Dec 2024
Modality
Small Molecules
01

Overview

A Phase 2 trial of vinorelbine, gemcitabine in breast cancer, sponsored by Shandong Cancer Hospital. Status: unknown.

02

Drugs

vinorelbinegemcitabine
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT04143906.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04143906.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call